Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
450.00    0.00 (0.00%)
Bid:
440.00
Ask:
510.00
Spread: 70.00 (15.909%)
Market Cap: £11.32b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Sale of Initial Facilities

28 Feb 2014 07:02

RNS Number : 1830B
Rentokil Initial PLC
28 February 2014
 



 

 

 

28 February, 2014

 

Rentokil Initial announces the sale of Initial Facilities

 

Rentokil Initial plc (FTSE: RTO, "the Company") announces today that it has agreed the sale of its Initial Facilities ("IFS") business to Interserve Plc for a total cash consideration of £250m. Completion, which is subject to the agreement of Interserve's shareholders at a General Meeting on 17 March, is expected by the end of March 2014.

 

In 2013 Rentokil Initial indicated that Initial Facilities was a non-core business for the Company. Its disposal, following that of City Link last year, will enable Rentokil Initial to focus on its three core route-based categories of Pest Control, Hygiene and Workwear. Excluding Initial Facilities, the Company's total revenue for the year ended 31 December 2013 was £1.76bn.

 

Post disposal the underlying financial metrics of Rentokil Initial will be significantly enhanced:

 

*Actual 2013 (incl. IFS) Proforma 2013 (excl. IFS)

Net operating margin 11.2% 13.1%

Organic growth -1.2% +0.5%

APBITA growth +4.1% +6.4%

 

* (at Constant Exchange Rates)

 

Initial Facilities delivered adjusted operating profit of £25.8m on revenues of £534.0m for the year ended 31 December 2013. The business has gross assets of £229.6m.

 

Andy Ransom, Chief Executive of Rentokil Initial Plc, said:

 

"This transaction really is a 'win win win'. It is an excellent outcome for our colleagues and customers in Initial Facilities, it represents a great opportunity for Interserve and it is absolutely the right deal for Rentokil Initial and its shareholders.

 

"Proceeds from the sale will be used primarily to pay down debt. We are now in a terrific position to focus capital and resources on our core route-based categories of Pest Control, Hygiene and Workwear, and over time we will also look to make further acquisitions in these core businesses."

 

-- Ends --

 

Notes to Editors

 

Preliminary Results for the year ended 31 December 2013

 

A presentation for investors and analysts will be held on Friday 28 February 2014 at 8.45am at the Inmarsat Conference Centre, 99 City Road, London, EC1Y 1AX. This will be available via a live audio web cast at www.rentokil-initial.com.

 

 

 

Rentokil Initial:

 

Rentokil Initial is one of the largest business services companies in the world, operating in over 60 countries. The company offers route-based services including pest control, hygiene and workwear through teams of local experts.

 

www.rentokil-initial.com

 

 

 

Enquiries:

 

Investors / Analysts enquiries:

Katharine Rycroft, Investor Relations Rentokil Initial plc 07811 270 734

 

Media enquiries:

Malcolm Padley, Corporate Communications Rentokil Initial plc 07788 978 199

Justine McIlroy / Nina Coad / Oliver Hughes Brunswick Group 020 7404 5959

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DOCGDGDDCXDBGSI
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.